| Announce Date | 08/06/2025 | 
| EPS Normalized Actual | $0.16 (Beat by $0.04) | 
| EPS GAAP Actual | $0.16 (Beat by $0.04) | 
| Revenue Actual | $1.99952B | 
| Revenue Surprise | Beat by $1999.52M | 
| Announce Date | 10/01/2025 (Pre-Market) | 
| EPS Normalized Estimate | $0.145 | 
| EPS GAAP Estimate | $0.145 | 
| Revenue Estimate | $2.388297B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Dec 2029 | 0 | INF | 0 | 0 | 0 | 
| Dec 2028 | 0.4 | 10.71 | 0.38562 | 0.41835 | 1 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.1637 | 0.0337 | 1.99952B | 100% | -395.4M | 
| FQ1 2025 (Mar 2025) | -0.12 | 0.065 | 1.8289B | 100% | -231.81M | 
| FQ4 2024 (Dec 2024) | -0.072 | -0.072 | 1.99211B | 100% | 1992.11M | 
| FQ3 2024 (Sep 2024) | 0.23 | 0.23 | 0.025749B | 100% | 25.75M | 
| FQ3 2012 (Sep 2012) | 0.0038 | 0.0038 | 0.310854B | 100% | 310.85M | 
| FQ4 2012 (Dec 2012) | -0.0011 | -0.0011 | 0.276882B | 100% | 276.88M | 
| FQ1 2013 (Mar 2013) | -0.0042 | -0.0042 | 0.254729B | 100% | 254.73M | 
| FQ2 2013 (Jun 2013) | 0.0015 | 0.0015 | 0.27598B | 100% | 275.98M | 
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.145
Consensus Revenue Estimates
2.388297B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.01 | -- | 0.00972378 | 0.01031625 | 1 | 
| FQ3 2027 (Sep 2027) | 0.16 | -- | 0.15532 | 0.16363 | 1 | 
| FQ2 2027 (Jun 2027) | 0.1 | -- | 0.09707582 | 0.10227 | 1 | 
| FQ1 2027 (Mar 2027) | -0.2 | -- | -0.20632 | -0.19448 | 1 | 
| FQ4 2026 (Dec 2026) | 0.0459 | -- | 0.04316611 | 0.04849268 | 1 | 
| FQ3 2026 (Sep 2026) | 0.1552 | -- | 0.14596 | 0.16397 | 1 | 
| FQ2 2026 (Jun 2026) | 0.1422 | -15.12 | 0.13373 | 0.15023 | 1 | 
| FQ1 2026 (Mar 2026) | -0.1636 | 26.65 | -0.17284 | -0.15386 | 1 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.87B | -- | 1.83B | 1.91B | 2 | 
| FQ3 2027 (Sep 2027) | 2.04B | -- | 1.99B | 2.07B | 2 | 
| FQ2 2027 (Jun 2027) | 1.96B | -- | 1.92B | 2B | 2 | 
| FQ1 2027 (Mar 2027) | 1.76B | -- | 1.72B | 1.8B | 2 | 
| FQ4 2026 (Dec 2026) | 3.95B | -- | 3.77B | 4.12B | 1 | 
| FQ3 2026 (Sep 2026) | 3.71B | -- | 3.54B | 3.88B | 1 | 
| FQ2 2026 (Jun 2026) | 3.49B | 42.77 | 3.33B | 3.65B | 1 | 
| FQ1 2026 (Mar 2026) | 3.29B | 44.36 | 3.14B | 3.43B | 1 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.13 | 0.1637 | 0.0337 | 20.59% | 
| FQ1 2025 (Mar 2025) | -0.185 | -0.12 | 0.065 | -54.17% | 
| FQ4 2024 (Dec 2024) | -0.072 | -0.072 | 100% | |
| FQ3 2024 (Sep 2024) | 0.23 | 0.23 | 100% | |
| FQ3 2012 (Sep 2012) | 0.0038 | 0.0038 | 100% | |
| FQ4 2012 (Dec 2012) | -0.0011 | -0.0011 | 100% | |
| FQ1 2013 (Mar 2013) | -0.0042 | -0.0042 | 100% | |
| FQ2 2013 (Jun 2013) | 0.0015 | 0.0015 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $2.39B | $2B | $-395.4M | -19.77% | 
| FQ1 2025 (Mar 2025) | $2.06B | $1.83B | $-231.81M | -12.67% | 
| FQ4 2024 (Dec 2024) | $0B | $1.99B | $1992.11M | 100% | 
| FQ3 2024 (Sep 2024) | $0B | $0.03B | $25.75M | 100% | 
| FQ3 2012 (Sep 2012) | $0B | $0.31B | $310.85M | 100% | 
| FQ4 2012 (Dec 2012) | $0B | $0.28B | $276.88M | 100% | 
| FQ1 2013 (Mar 2013) | $0B | $0.25B | $254.73M | 100% | 
| FQ2 2013 (Jun 2013) | $0B | $0.28B | $275.98M | 100% |